about
Sudden unexpected death in epilepsy: fatal post-ictal respiratory and arousal mechanismsFaulty cardiac repolarization reserve in alternating hemiplegia of childhood broadens the phenotypeDissecting the phenotypes of Dravet syndrome by gene deletionGenetic background modulates impaired excitability of inhibitory neurons in a mouse model of Dravet syndromeMechanisms of sudden unexplained death in epilepsyComprehensive care of children with Dravet syndromeSudden unexpected death in a mouse model of Dravet syndrome.Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibilityMapping genetic modifiers of survival in a mouse model of Dravet syndrome.Antecollis and levodopa-responsive parkinsonism are late features of Dravet syndrome.Complex febrile seizures: a practical guide to evaluation and treatment.Correlations in timing of sodium channel expression, epilepsy, and sudden death in Dravet syndrome.Impaired excitability of somatostatin- and parvalbumin-expressing cortical interneurons in a mouse model of Dravet syndromeEffect of vagus nerve stimulation in an adult patient with Dravet syndrome: contribution to sudden unexpected death in epilepsy risk reduction?.Tau reduction prevents disease in a mouse model of Dravet syndromeMaturation of EEG oscillations in children with sodium channel mutations.Pharmacotherapy for Dravet Syndrome.Cognitive Deficits Associated with Nav1.1 Alterations: Involvement of Neuronal Firing Dynamics and OscillationsSpecific deletion of NaV1.1 sodium channels in inhibitory interneurons causes seizures and premature death in a mouse model of Dravet syndrome.Autistic-like behaviour in Scn1a+/- mice and rescue by enhanced GABA-mediated neurotransmission.A human Dravet syndrome model from patient induced pluripotent stem cells.Sudden unexpected death in epilepsy genetics: Molecular diagnostics and preventionCardiac arrhythmia in a mouse model of sodium channel SCN8A epileptic encephalopathyAudit of use of stiripentol in adults with Dravet syndromeGenomic biomarkers of SUDEP in brain and heart.SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome.Novel animal models of pediatric epilepsy.Dravet syndrome: seizure control and gait in adults with different SCN1A mutations.Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.The ketogenic diet in Dravet syndrome.Stiripentol in Dravet syndrome: results of a retrospective U.S. study.The SCN1A gene variants and epileptic encephalopathies.Clinical management of epileptic encephalopathies of childhood and infancy.Epidemiologic aspects: lost in transition.Diagnostic Approach to Genetic Causes of Early-Onset Epileptic Encephalopathy.Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient population.Dravet Syndrome: Diagnosis and Long-Term Course.Palliative epilepsy surgery in Dravet syndrome-case series and review of the literature.Dysarthria and broader motor speech deficits in Dravet syndrome.Behavioral Comorbidities and Drug Treatments in a Zebrafish scn1lab Model of Dravet Syndrome.
P2860
Q27013739-7393641C-CCBF-4E04-807B-6D5BFF8703EDQ27303611-D28D9BBD-6912-4745-AF01-4DD480E3A05BQ27303721-277F662F-A65B-42F3-81B0-4F3E725C01DFQ27308208-BE4FF7EE-A160-430B-8415-C50A5A9B7618Q28081176-73CCCC02-C895-4C48-A979-F102BC339B2DQ29030607-885805FF-A3FA-403B-8101-D4255C6A674CQ30538288-7C9AB294-FB2C-40F0-BB55-F2B136807597Q30542513-5C35EA9C-7158-49B9-A08C-6A763411C648Q30572370-A1C4CD84-7240-4EEF-9A10-61A0D70374D9Q30585082-B7EEFAFA-AC34-441F-9BBD-B0C5515EAAB7Q30615069-8EA6C00C-C3D6-43A4-8BFC-9D78FB03F90BQ33702545-5744A601-DB57-42CE-A7C4-E8D1C152E230Q34002328-2EBE11BA-9922-49C0-959F-D23121F84B67Q34315236-2F0360BA-4082-4884-B682-986CDA79BF15Q35115219-C1D56D72-7ECC-42E2-AC00-89279EE35544Q35754275-AE80CA79-0749-4F29-A60E-C03B2BD9AE00Q35953476-AA9B2E99-9C61-46CE-9BB0-136645A793EEQ35957678-4D297E86-B6CC-4099-90CD-894CAEE3539CQ36221618-8CBAD797-E66C-4516-BEC8-42DE853AF879Q36252621-E6FDB1B0-06A5-47E8-814D-063EF68ABE34Q36849503-F825A081-5C16-45F6-A935-1FE2D31AEF6EQ37279519-EFBE516D-68BC-473E-BB7E-BF04519BA2A1Q37417878-5E4DBB1D-1DF9-41B2-8C08-41AA87141652Q37505426-E7A37F67-D50B-4CDA-9728-398A1A2F9537Q37707209-80C0C69E-52CB-4BDB-8375-0F5D7DFCDB23Q37985147-FB5BE2FE-9FFC-400F-9AA2-36AF3A478B72Q37998957-0BE046BD-F158-405E-AB5B-1771CAE9BD2DQ38025195-1A774AB4-01B3-4B9F-BA9E-158D140D5755Q38075436-D3F8F4D1-D29D-49E1-89AB-5EF93EF9A5E1Q38105061-AA9362E6-09CC-4CA8-9A33-B448C9BF7BA4Q38121171-05527E74-E47D-4C37-8DE9-4CC221CF2EC2Q38123956-39934229-5D7B-454A-97E5-FADEB8A73B8CQ38213837-DF2AB75E-7BC4-4151-9CAF-CD8281A113A0Q38248200-A4A14F35-AD21-42A5-AD6F-0B218757ED36Q38566303-C29471F8-F859-4F93-964F-F271FC46A053Q38681023-4AAC9E18-6F28-40A2-ADDA-D8536062916CQ38855478-260B2AA0-AC56-4B2D-9570-36039A4822FCQ38910600-7BDF310E-4ECA-4F6B-ABD9-7957BD965A31Q38985804-93558AEF-9A06-48C3-8217-7EED98419269Q41379608-20A504DD-BC03-4252-90EB-E6F6B76C0826
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Dravet syndrome: the long-term outcome.
@en
Dravet syndrome: the long-term outcome.
@nl
type
label
Dravet syndrome: the long-term outcome.
@en
Dravet syndrome: the long-term outcome.
@nl
prefLabel
Dravet syndrome: the long-term outcome.
@en
Dravet syndrome: the long-term outcome.
@nl
P2093
P2860
P1433
P1476
Dravet syndrome: the long-term outcome.
@en
P2093
Charlotte Dravet
Pierre Genton
Reana Velizarova
P2860
P356
10.1111/J.1528-1167.2011.03001.X
P478
52 Suppl 2
P577
2011-04-01T00:00:00Z